Clift, R A <br/><br/>
Marrow transplantation for patients in accelerated phase of chronic myeloid leukemia.  [electronic resource] 

 -  Blood  Dec 1994 
 - 4368-73 p.  digital 
<br/><br/> Publication Type: Clinical Trial; Clinical Trial, Phase I; Clinical Trial, Phase II; Comparative Study; Journal Article; Randomized Controlled Trial; Research Support, U.S. Gov't, P.H.S.; Review 
<br/><br/><label>ISSN: </label>0006-4971 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Acute Disease<br/>Adult<br/>Bone Marrow Transplantation--mortality<br/>Busulfan--administration & dosage<br/>Cause of Death<br/>Child<br/>Combined Modality Therapy<br/>Cyclophosphamide--administration & dosage<br/>Female<br/>Graft vs Host Disease--prevention & control<br/>Granulocyte Colony-Stimulating Factor--therapeutic use<br/>Granulocyte-Macrophage Colony-Stimulating Factor--therapeutic use<br/>Humans<br/>Immunologic Factors--therapeutic use<br/>Infections--etiology<br/>Interferons--therapeutic use<br/>Leukemia, Myelogenous, Chronic, BCR-ABL Positive--drug therapy<br/>Leukemia, Myeloid, Accelerated Phase--mortality<br/>Life Tables<br/>Male<br/>Middle Aged<br/>Multivariate Analysis<br/>Prognosis<br/>Recombinant Proteins--therapeutic use<br/>Retrospective Studies<br/>Salvage Therapy<br/>Spleen--pathology<br/>Splenectomy<br/>Survival Analysis<br/>Time Factors<br/>Treatment Outcome<br/>Washington--epidemiology<br/>Whole-Body Irradiation--adverse effects